2-(4-氯苯基)-4-三氟甲基-1H-咪唑 | 33469-15-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 2-(4-氯苯基)-4-三氟甲基-1H-咪唑
• 中文别名: 2-对氯苯基-4-三氟甲基咪唑；2-(4-氯苯基)-5-(三氟甲基)-1H-咪唑；2-(4-氯苯基)-4-(三氟甲基)-1H-咪唑
• 英文名称: 2-(4-chlorophenyl)-4-trifluoromethyl-1H-imidazole
• 英文别名: 2-(4-chloro-phenyl)-4-trifluoromethyl-1(3)H-imidazole；2-(4-Chlorophenyl)-4-(trifluoromethyl)-1H-imidazole；2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-imidazole
• CAS: 33469-15-7
• 化学式: C₁₀H₆ClF₃N₂
• mdl: MFCD08460500
• 分子量: 246.619
• InChiKey: ZTXYPSFNTFQYBS-UHFFFAOYSA-N

物化性质

• 熔点：
  218-221 °C
• 沸点：
  362.1±42.0 °C(Predicted)
• 密度：
  1.436±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  28.7
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2933290090

反应信息

• 作为反应物：
  描述：

  2-(4-氯苯基)-4-三氟甲基-1H-咪唑 在 水 、 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 24.0h， 以64%的产率得到2-(4-chlorophenyl)-1H-imidazole-5-carboxylic acid
  参考文献：
  名称：

  合成，抗病毒效力，体外ADMET和有效CD4模拟物的X射线结构，它们是针对HIV-1 gp120的Phe43腔的进入抑制剂。

  摘要：

  为了优化HIV-1进入前导拮抗剂NBD-11021，我们在本研究中提出了60种新类似物的合理设计和合成，并在单周期和多周期感染试验中确定了其抗病毒活性，从而得出了一种新的抗病毒药物。全面的结构－活动关系（SAR）。在针对一大批Env假型病毒的单周期分析中，与先导进入拮抗剂相比，其中两种化合物NBD-14088和NBD-14107在抗病毒活性方面显示出显着改善。相似化合物NBD-14010的X射线结构证实了新设计化合物的结合模式。这些化合物的体外ADMET谱与最有效的附着抑制剂BMS-626529相当，后者的前药目前正在接受III期临床试验。

  DOI：

  10.1021/acs.jmedchem.7b00179
• 作为产物：
  描述：

  4-氯苯甲醛 、 1,1-二溴-3,3,3-三氟丙酮 在 sodium acetate 、 ammonium hydroxide 作用下， 以 甲醇 为溶剂， 反应 20.5h， 以88%的产率得到2-(4-氯苯基)-4-三氟甲基-1H-咪唑
  参考文献：
  名称：

  Synthesis, Structure, and Neuroprotective Properties of Novel Imidazolyl Nitrones

  摘要：

  A new series of imidazolyl nitrones spin traps has been synthesized and evaluated pharmacologically. The salient structural feature of these molecules is the presence of an imidazole moiety substituted by aromatic or heteroaromatic cycles. This connectivity imparts to the nitrone superior neuroprotective properties in vivo and in parallel reduced side effects and toxicity. Thus compound 6a (a 2-phenylimidazolyl nitrone) administered intraperitoneally protects (80%) mice from lethality induced by an intracerebroventricular administration of tert-butyl hydroperoxide (t-BHP) an oxidant capable of inducing neurodegenerative processes. Administration of the archetypal nitrone phenyl-tert-butyl nitrone (PBN) at an equimolar dose also affords some protection (60%) in this test. However, this activity is accompanied by hypothermia, whereas no such effect is apparent for 6a. Moreover, previously prepared nonsubstituted or alkyl-substituted imidazolyl nitrones were shown to be extremely toxic to rats in contrast to the compounds prepared in this study. The observed activities in vivo correlate well with the calculated partition coefficients (ClogP) and HOMO energy level.

  DOI：

  10.1021/jm991154w

文献信息

• Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120
  作者：Francesca Curreli、Young Do Kwon、Dmitry S. Belov、Ranjith R. Ramesh、Alexander V. Kurkin、Andrea Altieri、Peter D. Kwong、Asim K. Debnath

  DOI：10.1021/acs.jmedchem.7b00179

  日期：2017.4.13

  entry antagonist, NBD-11021, we present in this study the rational design and synthesis of 60 new analogues and determination of their antiviral activity in a single-cycle and a multicycle infection assay to derive a comprehensive structure–activity relationship (SAR). Two of these compounds, NBD-14088 and NBD-14107, showed significant improvement in antiviral activity compared to the lead entry antagonist

  为了优化HIV-1进入前导拮抗剂NBD-11021，我们在本研究中提出了60种新类似物的合理设计和合成，并在单周期和多周期感染试验中确定了其抗病毒活性，从而得出了一种新的抗病毒药物。全面的结构－活动关系（SAR）。在针对一大批Env假型病毒的单周期分析中，与先导进入拮抗剂相比，其中两种化合物NBD-14088和NBD-14107在抗病毒活性方面显示出显着改善。相似化合物NBD-14010的X射线结构证实了新设计化合物的结合模式。这些化合物的体外ADMET谱与最有效的附着抑制剂BMS-626529相当，后者的前药目前正在接受III期临床试验。
• Synthesis, Structure, and Neuroprotective Properties of Novel Imidazolyl Nitrones
  作者：Alain Dhainaut、André Tizot、Eric Raimbaud、Brian Lockhart、Pierre Lestage、Solo Goldstein

  DOI：10.1021/jm991154w

  日期：2000.6.1

  A new series of imidazolyl nitrones spin traps has been synthesized and evaluated pharmacologically. The salient structural feature of these molecules is the presence of an imidazole moiety substituted by aromatic or heteroaromatic cycles. This connectivity imparts to the nitrone superior neuroprotective properties in vivo and in parallel reduced side effects and toxicity. Thus compound 6a (a 2-phenylimidazolyl nitrone) administered intraperitoneally protects (80%) mice from lethality induced by an intracerebroventricular administration of tert-butyl hydroperoxide (t-BHP) an oxidant capable of inducing neurodegenerative processes. Administration of the archetypal nitrone phenyl-tert-butyl nitrone (PBN) at an equimolar dose also affords some protection (60%) in this test. However, this activity is accompanied by hypothermia, whereas no such effect is apparent for 6a. Moreover, previously prepared nonsubstituted or alkyl-substituted imidazolyl nitrones were shown to be extremely toxic to rats in contrast to the compounds prepared in this study. The observed activities in vivo correlate well with the calculated partition coefficients (ClogP) and HOMO energy level.
• Transformation of Anionically Activated Trifluoromethyl Groups to Heterocycles under Mild Aqueous Conditions
  作者：Jennifer X. Qiao、Tammy C. Wang、Carol Hu、Jianqing Li、Ruth R. Wexler、Patrick Y. S. Lam

  DOI：10.1021/ol200326u

  日期：2011.4.1

  The (hetero)aromatic trifluoromethyl group is present in many biologically active molecules and is generally considered to be chemically stable. In this paper, a convenient one-step synthesis of C-C linked aryl-heterocycles or heteroaryl-heterocycles In good to excellent yields via the reaction of anionically activated trifluoromethyl groups with amino nucleophiles containing a second NH, OH, or SH nucleophile in 1 N sodium hydroxide is reported. The method has high functional group tolerability and is potentially useful in parallel synthesis.
• Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases (IBD)
  作者：Ling Li、Sijie Yuan、Lin Lin、Fang Yang、Ting Liu、Chenglong Xu、Huiting Zhao、Jingxuan Chen、Peihua Kuang、Ting Chen、Wenzhen Liao、Jianjun Chen

  DOI：10.1016/j.bioorg.2022.105619

  日期：2022.3